MICA/B (F-6) Antibody sc-137242 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemMICA/B (F-6) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-137242
Antibody TypePrimary Antibodies
NCBI Gene AliasesPERB11.1, MIC-A, PERB11.2
CloneF-6
Quantity200 µg/ml
ClonalityMonoclonal
ApplicationsWB, IP, IF, IHC(P), ELISA
Conjugate/TagUnconjugated
Reactivityhuman
FormatPurified
Hostmouse
NCBI Full Gene NameMHC class I polypeptide-related sequence A, MHC class I polypeptide-related sequence B
TargetMICA
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Breast cancer bone metastasis and bone metastatic cells retain NKG2DLs intracellularly: could this be a strategy to evade immune recognition?Frontiers in Cell and Developmental BiologyJanuary 27, 2026Marta Gomarasca, Paola Maroni, Chiara Verdelli, Laura Gerosa, Martina Faraldi, Alessandro Luzzati, Luca Cannavò, Giuseppe Banfi, Giovanni Lombardi(v/v) H2O2 and blocked with normal serum. Each specimen was assayed with anti-MICA/B [F-6] (1:50) (sc-137242, Santa Cruz Biotechnology), and anti-ULBP2 (1:300) (MA5-29636, Invitrogen, ThermoFisher Scientific)

(2) Characterization of senescence and nuclear reorganization in aging gingival cellsNPJ AgingFebruary 21, 2025Christian Fernández, Diego Ormeno, Verónica Villalobos, Mauricio Garrido, Javiera Canelo, Oscar Cerda, Felipe Maldonado, Mónica Caceres#NB100-304), Nectin-2/CD112 (Santa Cruz Biotechnology #sc-373715) 1/50, MICA/B (Santa Cruz Biotechnology #sc-137242) 1/50, p16 (Invitrogen #MA5-17142) 1/100, for immunofluorescence stained (IHC-F). For negative control

(3) Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkageSignal Transduct Target TherJanuary 20, 2025Ji Eon Kim, Hyun Su Kim, Wonsik Kim, Eun Hae Lee, Soyeon Kim, Taewoo Kim, Eun-Ae Shin, Kyung-Hee Pyo, Haesong Lee, Seo Hee Jin, et al.(#9102), HA (#3724; all from Cell Signaling Technology. Danvers, MA), α-tubulin (sc-5286), MICA/B (sc-137242), IL-6Rα (sc-661), pY861FAK (sc-16663), β-ACTIN (sc-47778), SLAMF7 (sc-390840), EGFR (sc-03), STAT3

(4) Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcomaCancer InnovationApril 8, 2024Satoru Sasagawa, Jun Kumai, Toru Wakamatsu, Yoshihiro Yuiinterest. 2.6 Western blot analysis Antibodies used for western blot analysis are as follows: anti‐MICA/B (#sc137242, 1:200; Santa Cruz Biotechnology), anti‐Twist1 (#sc81417, 1:500; Santa Cruz Biotechnology), anti‐MHC

(5) MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cellsPloS oneJanuary 1, 2021Ding H, Buzzard GW, Huang S, Sehorn MG, Marcus RK, Wei Y.Institutes of Health). The following antibodies were used in Western blot: monoclonal mouse antihuman MICA (sc-137242), PRL (sc-46698), PRLR (sc-377098) antibodies, mouse IgG light chain binding protein conjugated to HRP

(6) Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axisRNA biologyNovember 1, 2019Ou ZL, Luo Z, Wei W, Liang S, Gao TL, Lu YB.

(7) Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expressionJournal of surgical oncologySeptember 1, 2017Murakami T, Homma Y, Matsuyama R, Mori R, Miyake K, Tanaka Y, Den K, Nagashima Y, Nakazawa M, Hiroshima Y, et al.

(8) Propionibacterium acnes overabundance and natural killer group 2 member D system activation in corpus-dominant lymphocytic gastritisThe Journal of pathologyDecember 1, 2016Montalban-Arques A, Wurm P, Trajanoski S, Schauer S, Kienesberger S, Halwachs B, Högenauer C, Langner C, Gorkiewicz G.

(9) Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinomaCancer scienceFebruary 1, 2016Tsukagoshi M, Wada S, Yokobori T, Altan B, Ishii N, Watanabe A, Kubo N, Saito F, Araki K, Suzuki H, et al.Carpinteria, CA, USA) for 40 min. Next, the sections were incubated with primary mouse anti‐MICA/B mAbs (sc‐137242; Santa Cruz Biotechnology, Santa Cruz, CA, USA), a rabbit anti‐ULBP1 polyclonal Ab (A42608; Atlas Antibodies,

(10) MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell linesCancer cell internationalJune 1, 2011Del Toro-Arreola S, Arreygue-Garcia N, Aguilar-Lemarroy A, Cid-Arregui A, Jimenez-Perez M, Haramati J, Barros-Nuñez P, Gonzalez-Ramella O, Del Toro-Arreola A, Ortiz-Lazareno P, et al.

Be the First to Write a Review!

MICA/B (F-6) Antibody

MICA/B (F-6) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (10)

Reviews

MICA/B (F-6) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map